Prot #CPI 0610-04: A Phase 3, Randomized, Double-blind, Active-Control Study of CPI-0610 and Ruxolitinib vs. Placebo and Ruxolitinib in JAKi Treatment Naive MF Patients (MANIFEST-2)

Stein, Brady Lee (PD/PI)

Medicine, Hematology Oncology Division

Project: Research project

Status	Finished
Effective start/end date	7/26/21 → 7/26/24

Funding

Novella Clinical, LLC ((OE) Prot#CPI 0610-04 // (OE) Prot#CPI 0610-04)
Constellation Pharmaceuticals, Inc. ((OE) Prot#CPI 0610-04 // (OE) Prot#CPI 0610-04)